BNP Paribas Financial Markets
HARP

BNP Paribas Financial Markets’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

BNP Paribas Financial Markets’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43
Closed -$304 – 4080
2023
Q2 		$304 Hold
43
– – ﹤0.01% 3813
2023
Q1 		$319 Sell
43
-100
-70% -$841 ﹤0.01% 3742
2022
Q4 		$1.04K Sell
143
-95
-40% -$800 ﹤0.01% 3798
2022
Q3 		$2.31K Sell
238
-1,061
-82% -$19.8K ﹤0.01% 4331
2022
Q2 		$24.8K Buy
1,299
+1,106
+573% +$28.6K ﹤0.01% 3673
2022
Q1 		$9.61K Sell
193
-240
-55% -$12.4K ﹤0.01% 3809
2021
Q4 		$32.7K Buy
433
+57
+15% +$3.89K ﹤0.01% 3806
2021
Q3 		$29.7K Buy
376
+284
+309% +$28.5K ﹤0.01% 3607
2021
Q2 		$12.7K Sell
92
-78
-46% -$14.9K ﹤0.01% 3664
2021
Q1 		$35.6K Sell
170
-28
-14% -$5.61K ﹤0.01% 3683
2020
Q4 		$32.8K Sell
198
-53
-21% -$8.19K ﹤0.01% 3722
2020
Q3 		$42.6K Buy
251
+211
+528% +$30.4K ﹤0.01% 3552
2020
Q2 		$6.59K Sell
40
-187
-82% -$29.2K ﹤0.01% 3888
2020
Q1 		$26.3K Buy
227
+81
+55% +$11.4K ﹤0.01% 3828
2019
Q4 		$21.6K Buy
146
+84
+135% +$12.7K ﹤0.01% 3979
2019
Q3 		$8.52K Buy
62
+12
+24% +$1.69K ﹤0.01% 4187
2019
Q2 		$6.45K Buy
+50
New +$5.81K ﹤0.01% 4199

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BNP Paribas Financial Markets's HARP Position: Q3 2023 in Review

BNP Paribas Financial Markets sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2023, closing a stake of 43 shares — an estimated $304 sold.

BNP Paribas Financial Markets first reported a position in HARP in Q2 2019 and held it in 17 quarters. The position peaked at $42.6K in Q3 2020. 32 funds tracked by Wall St. Rank hold HARP as of Q3 2023.

  • BNP Paribas Financial Markets reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 43 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $304.
  • BNP Paribas Financial Markets first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2019 and held it in 17 quarters.
  • BNP Paribas Financial Markets's Harpoon Therapeutics, Inc. Common Stock position peaked at $42.6K in Q3 2020.
  • 32 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2023, filed 14 Nov 2023.